Kezar Life Sciences, Inc. Files SEC Form 8-K, Current Report: (Oct. 17, 2024).

Kezar Life Sciences, Inc. filed a U.S. Securities and Exchange Commission (SEC) Form 8-K on October 17, 2024, with the SIC code for the company being 2834, Pharmaceutical Preparations. The filing, which included 19 documents, is a "current report" used to disclose material events or corporate changes important to investors. This formal document provides more current information than Forms 10-Q or 10-K and can be accessed on the SEC website for further details. [Extracted from the article]